TP53 and acute myeloid leukemia: The control sgRNAs associated with genes known to be crucial for AML cell proliferation were depleted(e.g., MYC, BCL2, MCL1, PCNA, and RPA1), while sgRNAs targeting tumor suppressor TP53 was enriched, and quantities of neutral sgRNAs remained essentially unchanged [103,112].